These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Surgical stress promotes tumor growth in ovarian carcinoma. Lee JW; Shahzad MM; Lin YG; Armaiz-Pena G; Mangala LS; Han HD; Kim HS; Nam EJ; Jennings NB; Halder J; Nick AM; Stone RL; Lu C; Lutgendorf SK; Cole SW; Lokshin AE; Sood AK Clin Cancer Res; 2009 Apr; 15(8):2695-702. PubMed ID: 19351748 [TBL] [Abstract][Full Text] [Related]
6. Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Alvero AB; Fu HH; Holmberg J; Visintin I; Mor L; Marquina CC; Oidtman J; Silasi DA; Mor G Stem Cells; 2009 Oct; 27(10):2405-13. PubMed ID: 19658191 [TBL] [Abstract][Full Text] [Related]
7. Biologic effects of dopamine on tumor vasculature in ovarian carcinoma. Moreno-Smith M; Lee SJ; Lu C; Nagaraja AS; He G; Rupaimoole R; Han HD; Jennings NB; Roh JW; Nishimura M; Kang Y; Allen JK; Armaiz GN; Matsuo K; Shahzad MM; Bottsford-Miller J; Langley RR; Cole SW; Lutgendorf SK; Siddik ZH; Sood AK Neoplasia; 2013 May; 15(5):502-10. PubMed ID: 23633922 [TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice. Kim LS; Huang S; Lu W; Lev DC; Price JE Clin Exp Metastasis; 2004; 21(2):107-18. PubMed ID: 15168728 [TBL] [Abstract][Full Text] [Related]
10. Chronic stress accelerates the development of endometriosis in mouse through adrenergic receptor β2. Long Q; Liu X; Qi Q; Guo SW Hum Reprod; 2016 Nov; 31(11):2506-2519. PubMed ID: 27664956 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy. Wood JM Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930 [TBL] [Abstract][Full Text] [Related]
12. The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockade. Sini P; Wyder L; Schnell C; O'Reilly T; Littlewood A; Brandt R; Hynes NE; Wood J Clin Cancer Res; 2005 Jun; 11(12):4521-32. PubMed ID: 15958638 [TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma. Hu L; Hofmann J; Jaffe RB Clin Cancer Res; 2005 Nov; 11(22):8208-12. PubMed ID: 16299254 [TBL] [Abstract][Full Text] [Related]
14. Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration. Xiao X; Yang M; Xiao J; Zou J; Huang Q; Yang K; Zhang B; Yang F; Liu S; Wang H; Bai P Cancer Chemother Pharmacol; 2014 Apr; 73(4):807-18. PubMed ID: 24638862 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model. Byrne AT; Ross L; Holash J; Nakanishi M; Hu L; Hofmann JI; Yancopoulos GD; Jaffe RB Clin Cancer Res; 2003 Nov; 9(15):5721-8. PubMed ID: 14654557 [TBL] [Abstract][Full Text] [Related]
17. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. Xu L; Yoneda J; Herrera C; Wood J; Killion JJ; Fidler IJ Int J Oncol; 2000 Mar; 16(3):445-54. PubMed ID: 10675474 [TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and ovarian cancer. Gómez-Raposo C; Mendiola M; Barriuso J; Casado E; Hardisson D; Redondo A Clin Transl Oncol; 2009 Sep; 11(9):564-71. PubMed ID: 19775995 [TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas. Farhadi MR; Capelle HH; Erber R; Ullrich A; Vajkoczy P J Neurosurg; 2005 Feb; 102(2):363-70. PubMed ID: 15739567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]